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A B S T R A C T
Background: Results on the association between prenatal exposure to methylmercury (MeHg) and child
neuropsychological development are heterogeneous. Underlying genetic diﬀerences across study populations
could contribute to this varied response to MeHg. Studies in Drosophila have identiﬁed the cytochrome p450 3A
(CYP3A) family as candidate MeHg susceptibility genes.
Objectives: We evaluated whether genetic variation in CYP3A genes inﬂuences the association between prenatal
exposure to MeHg and child neuropsychological development.
Methods: The study population included 2639 children from three birth cohort studies: two subcohorts in
Seychelles (SCDS) (n = 1160, 20 and 30 months of age, studied during the years 2001–2012), two subcohorts
from Spain (INMA) (n = 625, 14 months of age, 2003–2009), and two subcohorts from Italy and Greece
(PHIME) (n = 854, 18 months of age, 2006–2011). Total mercury, as a surrogate of MeHg, was analyzed in
maternal hair and/or cord blood samples. Neuropsychological development was evaluated using Bayley Scales of
Infant Development (BSID). Three functional polymorphisms in the CYP3A family were analyzed: rs2257401
(CYP3A7), rs776746 (CYP3A5), and rs2740574 (CYP3A4).
Results: There was no association between CYP3A polymorphisms and cord mercury concentrations. The scores
for the BSID mental scale improved with increasing cord blood mercury concentrations for carriers of the most
active alleles (β[95% CI]: = 2.9[1.53,4.27] for CYP3A7 rs2257401 GG+GC, 2.51[1.04,3.98] for CYP3A5
rs776746 AA+AG and 2.31[0.12,4.50] for CYP3A4 rs2740574 GG+AG). This association was near the null for
CYP3A7 CC, CYP3A5 GG and CYP3A4 AA genotypes. The interaction between the CYP3A genes and total
mercury was signiﬁcant (p < 0.05) in European cohorts only.
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Conclusions: Our results suggest that the polymorphisms in CYP3A genes may modify the response to dietary
MeHg exposure during early life development.
1. Introduction
Methylmercury (MeHg) is a ubiquitous environmental toxicant that
derives from both natural sources and human activity (World Health
Organization (WHO), 2007a). MeHg is present in almost all aquatic
species as a result of the methylation of inorganic mercury by
microorganisms present in sediments (Parks et al., 2013) and subse-
quent bioaccumulation up the food chain. Human exposure occurs
almost exclusively through consumption of ﬁsh and marine mammals.
About 95% of the MeHg ingested from ﬁsh is absorbed into the
bloodstream and readily crosses the placental and blood–brain barrier
where it poses the greatest risk for developmental neurotoxicity (World
Health Organization (WHO), 2007b).
Several epidemiologic studies have examined the consequences of
prenatal MeHg exposure from maternal consumption of ﬁsh or seafood
on child cognitive and motor development and have found conﬂicting
results, with some studies reporting adverse associations and others
ﬁnding no inﬂuence of exposure on developmental outcomes (Davidson
et al., 2008; Grandjean et al., 1997; Llop et al., 2012; Valent et al.,
2013). Methodological diﬀerences, co-exposures to several environ-
mental pollutants and nutritional factors may have contributed to this
observed heterogeneity in eﬀect estimates. In addition, it has been
postulated that individual and population genetic diﬀerences may also
inﬂuence MeHg toxicity (Llop et al., 2015; National Research Council,
2000).
Only a few studies have addressed the role of genetics in MeHg
toxicity, with most studies based on adult populations (Llop et al.,
2015). Candidate genes in the glutathione (GSH) metabolism pathway
have been primarily considered since the formation of MeHg-GSH
conjugates are thought to be key to excretion (Ballatori and Clarkson,
1983; Barcelos et al., 2013; Custodio et al., 2004; Engstrom et al., 2008;
Engström et al., 2016; Gundacker et al., 2007). However, results have
been inconsistent regarding the modifying role of these genes. In an
attempt to identify MeHg tolerance and susceptibility genes through an
unbiased transcriptomic screen using developing neural tissue of
Drosophila several members of the Cytochrome p450 (CYPs) family
were resolved as gene candidates (Mahapatra et al., 2010). CYPs are a
superfamily of enzymes involved in oxidative metabolism of xenobio-
tics. Genetic polymorphism in these drug metabolizing enzymes is
considered to be a major contributor to individual susceptibility to
environmental, chemical and drug toxicity (Johansson and Ingelman-
Sundberg, 2011).
Functional studies in Drosophila showed that ectopic expression of
the Drosophila CYP6g1 gene, as well as expression of its human homolog
CYP3A4, in ﬂies, conferred tolerance to developmental MeHg toxicity
(Rand et al., 2012). The human CYP3A subfamily is comprised of four
distinct genes: CYP3A4, CYP3A5, CYP3A7 and CYP3A43, which are
located in close proximity on chromosome 7. CYP3A4, CYP3A5,
CYP3A7 are predominantly expressed in the liver, kidney and gut
tissues where they catalyze drug and xenobiotic metabolism
(Anzenbacher and Anzenbacherová, 2001). CYP3A enzymes are also
essential for the synthesis of endobiotics, such as sex hormones and
fatty acids (Hasler, 1999; Zanger and Schwab, 2013) that are crucial in
nervous system development. In a developmentally regulated process
CYP3A7 is preferentially expressed in human fetal liver which is
replaced with CYP3A4 expression postnatally (Hakkola et al., 1998).
The expression and function of CYP3A genes in extra-hepatic tissues are
less well characterized, nonetheless there is evidence for CYP3A
transcripts in developing brain (https://www.ebi.ac.uk/gxa/home).
While a direct role of CYPs in MeHg metabolism remains under
investigation (Rand et al., unpublished observations), early studies
have shown an ability of liver microsomes to biotransform MeHg to
inorganic Hg in vitro (Nakayama, 1976). Since MeHg de-methylation is
recognized as a rate-limiting step in MeHg elimination (Farris et al.,
1993; Smith et al., 1994), and correspondingly dictates the body burden
of MeHg, a potential enzymatic role for CYPs in mediating MeHg
metabolism presents an attractive hypothesis to explore in population
based studies.
Several single nucleotide polymorphisms (SNPs) in humans aﬀect
CYP3A expression and activity (Lamba et al., 2002). The CYP3A4 SNP
rs2740574 (also referred to as CYP3A4*1B, by The Human Cytochrome
P450 (CYP) Allele Nomenclature Database, http://www.cypalleles.ki.
se/) is a change in the promoter region that can potentially give higher
expression levels of CYP3A4 (Lamba et al., 2002). CYP3A5 rs776746
SNP (CYP3A5*3A) encodes a truncated mRNA transcript, resulting in
no protein expression (Knops et al., 2015). CYP3A7 rs2257401
(CYP3A7*2) is a non-synonymous coding SNP that yields an enzyme
with increased catalytic eﬃciency (Rodriguez-Antona et al., 2005). In
this study we examined whether these polymorphic variants of CYP3A
genes, which predict diﬀerent levels of CYP activity, modify the
association between prenatal exposure to MeHg and neurodevelop-
mental outcomes in children. We studied three birth cohorts from
coastal populations; the Seychelles Child Development Study (SCDS),
INMA – Environment and Childhood in Spain, and PHIME (Public
Health Impact of long-term, low-level Mixed Element Exposure in
susceptible population strata) in Italy and Greece. A lack of adverse
neurodevelopmental eﬀects during infancy associated with prenatal
MeHg in these birth cohorts has been previously reported (Davidson
et al., 2008; Llop et al., 2012; Strain et al., 2015; Valent et al., 2013).
2. Methods
2.1. Study population
The study participants were children from three established birth
cohort studies: one from the Republic of Seychelles and two from the
Mediterranean region. The study in Seychelles (SCDS) included two
subcohorts: Nutrition Cohort 1 (NC1) and 2 (NC2). The studies from the
Mediterranean area encompassed two subcohorts from Spain (INMA
study) and two subcohorts from Italy and Greece (PHIME project).
SCDS is a longitudinal observational study conducted in the
Republic of Seychelles, an archipelago of 115 islands in the Indian
Ocean (Strain et al., 2015); most of the population resides on the island
of Mahé where the study was conducted and the population is of mixed
African, European and East Asian descent. The overall aim of the SCDS
is to investigate the associations between child development outcomes
and MeHg and nutrients from maternal ﬁsh consumption during
pregnancy. Healthy mothers were recruited to NC1 and NC2 during
their ﬁrst antenatal visit (from 14 weeks of gestation) at eight health
centres across Mahé. NC1 mothers (n = 301) were recruited in 2001
(Davidson et al., 2008) and NC2 mothers (n = 1535) were enrolled
from 2008 until 2011 (Strain et al., 2015). Inclusion criteria included
being native Seychellois, at least 16 years of age, having a singleton
pregnancy, and no obvious health concerns. Exclusion criteria included
low birth weight and serious perinatal or neurological problems.
Neurodevelopment evaluations took place at 30 months of age for
NC1 (n = 276) and at 20 months of age for NC2 (n = 1457) children.
INMA is a multicentre birth cohort study, which aims to investigate
the eﬀect of environmental exposures and diet during pregnancy on
fetal and child development in diﬀerent geographical areas of Spain.
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Details of the INMA project and sampling procedures have been
described elsewhere (Guxens et al., 2012). Brieﬂy, pregnant women
in this study were recruited during the 1st trimester of pregnancy
(n = 1512) and followed until delivery (n = 1409) in two regions of
Spain: Valencia and Sabadell (2003–2007). The inclusion criteria were:
at least 16 years of age, 10–13 weeks of gestation, singleton pregnancy,
intention of undergoing follow-up and delivering in the corresponding
centre of reference, no impediment for communication, and no chronic
disease prior to pregnancy. Neurodevelopment evaluations took place
around 14 months of age (n = 1253). The data of these two subcohorts
was combined since they shared the same study protocol.
PHIME is a multicentre project that aims to evaluate the health
eﬀects of long-term exposure to low levels of metals, such as the eﬀects
of MeHg on the nervous system. This study included participants from
Italy and Greece (Valent et al., 2013); the study population consisted of
1366 women recruited in the Northern Adriatic province of Trieste
(Italy), and the Greek islands of Lesvos, Chios, Samos, and Leros in the
Eastern Aegean Sea. The pregnant women eligible for recruitment were:
residents of the study areas for at least 2 years, at least 18 years of age,
and no absence from the study area for> 6 weeks during pregnancy,
no history of drug abuse, no serious health problems or complications
of pregnancy or delivery, and no twin gestation. At recruitment, eligible
women were approached for consent after their routine morphologic
ultrasound scan between 20 and 22 gestational weeks (Italy,
2007–2009), or during their hospital stay for delivery (Greece,
2006–2009). Neurodevelopment evaluations took place around
18 months of age (n = 632 in Italy and n = 350 in Greece).
The ﬁnal study population consisted of children with available
information on prenatal mercury exposure, CYP3A genotype of the
child, and neurodevelopment test scores: 1160 from SCDS (211 from
NC1 and 949 from NC2), 625 from INMA, and 854 from PHIME (573
from Italy and 281 from Greece). Women participating in the original
studies signed a written informed consent form in each phase. The
Seychelles Ethics Board, the Research Subjects Review Board at the
University of Rochester, the Ethics Committees of La Fe Hospital in
Valencia, the Institut Municipal d'Assistència Sanitaria in Barcelona, the
Burlo Garofolo in Trieste, the Institute of Child Health in Athens, and
Lund University in Lund approved the study.
2.2. Mercury exposure
In SCDS NC1, INMA and PHIME, total mercury (THg) concentra-
tions were available in cord whole blood samples. THg was for all
cohorts measured by thermal decomposition, amalgamation, and atom-
ic absorption spectrometry. For the SCDS NC1, THg was measured at
the University of Rochester (Cernichiari et al., 1995). For INMA, THg
was measured in the Public Health Laboratory in Alava (LSPPV),
Basque Country (Ramon et al., 2011). For PHIME, THg was measured
in the laboratory of the Department of Environmental Sciences at the
Jozef Stefan Institute in Ljubljana, Slovenia (Miklavcic et al., 2013).
The limit of quantiﬁcation (LOQ) of the procedure was 1.9 ppb in SCDS,
0.07 ppb in PHIME, and 2.0 ppb in INMA. In INMA there were 30
samples below the LOQ and for those we used the approximation LOQ/
√2.
An interlaboratory comparison was made using INMA cord blood
samples (n = 12); where THg concentrations in these samples were
analyzed at the Jozef Stefan Institute (PHIME laboratory) and the
LSPPV (INMA laboratory). The correlation between the concentrations
obtained by the two laboratories was high (Spearman correlation
coeﬃcient = 0.993, p < 0.001).
Maternal hair samples were available at delivery to determine
prenatal THg exposure among SCDS NC1 and NC2 participants. THg
was measured by the standard technique of atomic absorption spectro-
scopy (Cernichiari et al., 1995) at the University of Rochester in the
longest hair segment available to reﬂect exposure throughout preg-
nancy. The LOQ was 0.61 ppm. THg was also analyzed in maternal hair
samples from the PHIME participants collected in Italy between the
weeks 20–22 and in Greece at delivery. THg was analyzed in the 1 cm of
hair closest to scalp at the Jozef Stefan Institute by thermal combustion,
amalgamation, and atomic absorption spectrometry using a direct
mercury analyzer (Milestone, USA). The LOQ of the procedure was
0.7 ng/g in PHIME (Miklavcic et al., 2013).
2.3. Genetic analysis
DNA was extracted from cord blood (cord tissue for the Italian
samples) by the Qiagen DNA Blood Mini kit (Qiagen, Hilden Germany;
for SCDS and PHIME), or by the Chemagen protocol (Baesweiler,
Germany; for INMA).
We focused on SNPs with a known functional impact on CYP3A
expression and activity. Three SNPs were analyzed, one in each of the
CYP genes: rs2257401 (CYP3A7), rs776746 (CYP3A5), and rs2740574
(CYP3A4). All SNPs were analyzed by Taqman assays apart for the
analysis of rs776746 and rs2740574 in INMA, where we took advan-
tage of a genome-wide genotyping already performed (rs2257401 was
not present on the BeadChip).
TaqMan allelic discrimination was performed on an ABI 7900
instrument (Applied Biosystems, Foster City, CA, USA), according to
the manufacturer's instructions. A random selection (at least 5%) of the
samples were re-analyzed for quality control purposes with perfect
agreement between original and repeat genotyping runs for all SNPs.
Diﬀerences in genotyping eﬃciency account for diﬀerent sample sizes
for each SNP. The identiﬁcation numbers for each assay designed by
Thermoﬁsher Scientiﬁc are found in (Supplementary Table S1).
Genotyping of rs776746 and rs2740574 in INMA was performed
using the Human Omni1-Quad BeadChip (lllumina, San Diego, CA,
USA) at the Spanish National Genotyping Centre (CEGEN, Barcelona).
Genotype calling was done using the GeneTrain2.0 algorithm based on
HapMap clusters implemented in the GenomeStudio Illumina software.
The following quality control thresholds were applied: sample call
rate> 98% and/or logRRatio SD< 0.3 (n = 4 individuals were ex-
cluded in Valencia). Sex, relatedness (excluded: one duplicated sample
and the younger brother of each of two brother-pairs detected in
Sabadell), and heterozygosity were checked. Principal component
analysis showed that there was no population stratiﬁcation in the
cohort. Genetic variants were ﬁltered for a SNP call rate> 95%, and
minor allele frequency (MAF)> 1%.
2.4. Neurodevelopment evaluation
In all birth cohorts, neurodevelopment of the children was assessed
using Bayley Scales of Infant Development (BSID). The BSID assesses
age-appropriate mental and psychomotor development expressed as
Mental Development Index (MDI) and Psychomotor Development Index
(PDI), including performance abilities, memory, early language skills,
psychomotor skills, and coordination.
In SCDS, BSID-II was used at 20 months of age (range: 15–25) for
NC2 and 30 months of age (range: 27–35) for NC1. Testing was
conducted at the Child Development Centre, Mahé by specially trained
nurses. In INMA, the BSID-I was used around 14 months of age (range
11–20). All testing was done in the health care centre in the presence of
the mother, by a total of 6 trained psychologists. In PHIME the BSID-III
was used around the age of 18 months (range 16–20). Testing was
conducted in the study hospitals in Italy and Greece by trained
paediatricians or psychologists.
The diﬀerent versions of the BSID utilize some diﬀerent test items
and are standardized on diﬀerent normative populations. To homo-
genize the scales and allow us to directly compare associations, all raw
scores were converted into standard deviation units (z-score equals raw
score subtracted from mean and divided by the standard deviation) and
then standardized to a mean of 100 and a standard deviation of 15 (new
score = 100 + (15 × z)).
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2.5. Other variables
Information about study population characteristics was obtained
through questionnaires administered during pregnancy (19th–36th
week) and at delivery in SCDS, during the ﬁrst (10–14th week) and
third (28–32nd week) trimester of pregnancy in INMA, during the third
(30–32nd week) trimester of pregnancy in PHIME-Italy, and at delivery
in PHIME-Greece. The variables used in this study were: maternal age at
delivery (years), educational level (up to primary, secondary, univer-
sity), ﬁsh intake during pregnancy (weekly servings), and tobacco
consumption during pregnancy (no, yes). A socioeconomic status (SES)
index was obtained in all cohorts. In SCDS, SES was measured as a
continuous variable by the Hollingshead Four-Factor Socioeconomic
Status scale modiﬁed for use in Seychelles (Davidson et al., 1998). In
INMA, the parental social class was deﬁned from the maternal or
paternal occupation during pregnancy with the highest social class,
according to a widely used Spanish adaptation of the International
Standard Classiﬁcation of Occupations approved in 1988 (ISCO88)
coding system. In PHIME SES index was deﬁned according to parental
educational level, parental occupation (ISCO88), employment status
during pregnancy (employed vs. not employed) and home ownership
(Bennett et al., 2007). To homogenize this variable among the cohorts a
three-category variable was calculated where the class I reﬂected the
highest social class and the class III the lowest one.
2.6. Statistical analysis
Diﬀerences in THg concentrations (geometric means and 95%
conﬁdence intervals (CI)) in relation to genotype were analyzed by
the Mann-Whitney test. When the frequency of variant homozygotes
was low (< 10%), variant homozygotes were pooled with heterozy-
gotes. For further analysis the log2 of THg concentrations was calcu-
lated, due to its skewed distribution.
Linear regression models assessed the inﬂuence of CYP genotypes on
the association between THg concentrations (in cord blood and
maternal hair) and the BSID scores by including the interaction term
log2-THg*genotype. The estimates for the association between the
scores and THg (both in cord blood and in maternal hair) within strata
deﬁned by genotypes were obtained for each country and were
subsequently combined using a meta-analysis approach. In order to
examine whether there was statistical heterogeneity, the I-squared
measure was quantiﬁed (I2) (Higgins et al., 2003). The ﬁxed eﬀects
model was used and, if heterogeneity was detected (I2 > 50%), we
applied the random eﬀects model. The interaction p-values were also
provided. Firstly, models were adjusted for children's age at testing and
child's sex (minimally adjusted models). Secondly, the models were
adjusted by common variables among the cohorts (common variables
adjusted models) that have been related to MDI and PDI in previous
studies (Llop et al., 2012; Strain et al., 2015; Valent et al., 2013).
Maternal ﬁsh consumption for the three cohorts was included in the
minimally adjusted models to evaluate change in eﬀect estimates. In all
analyses the same reference genotype was used, i.e. genotypes with the
higher activity allele.
Since the LD was low to moderate, the inﬂuence of the number of
CYP3A variant alleles on the modifying eﬀects on MDI and PDI was also
evaluated. A four category genetic variable was built in order to
evaluate any allele dosage eﬀect (0: no variant alleles; 1: 1 variant
allele; 2: 2 variant alleles; 3: 3 variant alleles).
The analyses were carried out using the Stata, version 13, statistical
package (StataCorp LP, College Station, Texas) and the R system
version 3.0.
3. Results
Maternal and child characteristics are presented in Table 1. Mothers
in NC1 and NC2 (Seychelles) were slightly younger than mothers in
INMA-Spain and PHIME-Italy and Greece. The percentage of mothers
with university degree was the lowest in PHIME-Greece, followed by
INMA-Spain, PHIME-Italy, NC1 and NC2-Seychelles. Nearly half of the
INMA-Spain mothers belonged to the lowest social class, followed by
women in PHIME-Italy, PHIME-Greece, NC1 and NC2-Seychelles. The
proportion of smokers was higher in the Mediterranean cohorts than in
Seychelles. THg concentrations in maternal hair and cord blood were
the highest in Seychelles (5.8 and 3.9 μg/g in NC1 &NC2 maternal hair
respectively and 39.3 μg/L in NC1 cord blood). Among the Mediterra-
nean cohorts, the highest cord blood THg concentrations were found in
INMA-Spain (11.3 μg/L), followed by PHIME-Greece (7.5 μg/L) and
ﬁnally PHIME-Italy (5.6 μg/L). The maternal ﬁsh consumption was
higher in Seychelles (9.1 meals/week in NC1 and 8.5 meals/week in
NC2), followed by INMA-Spain (6.2 meals/week), PHIME-Greece (3.2
Table 1
Distribution of maternal and child characteristics.
NC1-Seychelles
(%)
NC2-Seychelles
(%)
INMA-Spain (%) PHIME-Italy (%) PHIME-Greece (%) p-Valuec
Total 211 949 625 573 281
Maternal age at delivery (years)a 27.8 (6.0) 27.0 (6.3) 31.2 (4.3) 33.3 (4.4) 28.7 (6.4) < 0.001
Maternal education
Up to primary 0.5 0.4 30.2 17.3 22.8 < 0.001
Secondary 51.2 41.1 42.2 48.3 56.3
University 48.3 58.1 27.5 34.4 20.9
Social class
High 37.9 27.6 28.5 27.4 39.0 < 0.001
Medium 49.8 60.8 31.0 28.9 18.9
Low 12.3 11.6 40.5 43.7 42.0
Smoking habit during pregnancy
Smokers 2.8 0.8 18.5 11.6 16.6 < 0.001
Children's sex
Female 51.2 49.2 47.4 48.4 55.3 0.278
Children age at testing (months)a 27.9 (1.2) 20.3 (1.3) 13.4 (1.3) 18.7 (0.9) 18.5 (1.1) < 0.001
Maternal ﬁsh consumption (meals/week)a 9.1 (4.1) 8.5 (4.7) 6.2 (2.6) 2.5 (1.6) 3.2 (2.3) < 0.001
THg concentrations in maternal hair (μg/g)a,b 5.8 (3.7) 3.9 (3.5) Na 1.0 (1.0) 1.4 (1.1) < 0.001
THg concentrations in cord blood (μg/L)a,b 39.3 (25.5) Na 11.3 (9.8) 5.6 (4.8) 7.5 (5.8) < 0.001
Na: not available. THg: total mercury. SCDS-NC: The Seychelles Child Development Study Nutrition Cohort. INMA: Infancia y medio ambiente (i.e. Environment and Childhood). PHIME:
Public Health Impact of long-term, low-level Mixed Element Exposure in susceptible population strata.
a Mean (standard deviation).
b Italy: n = 453 for THg in cord blood and n = 571 for THg in maternal hair.
c Kruskal Wallis test for continuous variables and Chi2 for categorical variables.
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meals/week) and Italy (2.5 meals/week).
In all cohorts, the minor alleles of each CYP3A SNP correspond to
the higher-activity allele with respect to predicted CYP enzyme activity
(i.e., G in rs2257401 (CYP3A7), A in rs776746 (CYP3A5), and G in
rs2740574 (CYP3A4)), with the exception of SCDS where higher-
activity alleles A in rs776746 and G in rs2740574 were the major
alleles (Table 2). Across all Mediterranean cohorts, the MAFs for all
three CYP3A genes were relatively low (range from 1.4% to 12.4%),
with minor cohort-diﬀerences in MAF for each SNP, and similar to
reported MAFs for European populations (Supplementary Table S2). In
contrast, in Seychelles (NC1 and NC2) the MAFs were much higher than
the Mediterranean cohorts across all three CYP3A genes (range
44.8–55.1%, Table 2). These frequencies are similar to those previously
reported for African populations and are somewhat higher than
frequencies observed in Asian populations (Supplementary Table S2).
There was evidence of linkage disequilibrium (LD) between some of the
SNPs: the LD (r2) between rs776746 and rs2257401 were 0.39 in
PHIME-Greece, 0.56 in PHIME-Italy, 0.60 in SCDS and 0.73 in INMA.
The LD between all other SNP pairs was below 0.35. With respect to
THg concentrations in cord blood, no signiﬁcant diﬀerences were seen
as a function of CYP3A genotype (Table 2).
Eﬀect modiﬁcation of CYP3A genotype on the association between
prenatal exposure to MeHg and child neurodevelopment was evaluated.
For CYP3A7, the overall coeﬃcient of cord blood THg on MDI was
positive (i.e. improving MDI score with increasing cord blood THg
concentrations) and statistically signiﬁcant (β= 2.90; 95% CI 1.53,
4.27) for children carrying GG or GC (Fig. 1A). For children carrying
CC, this coeﬃcient became near null (β= 0.20; 95% CI −0.49, 0.89)
(Fig. 1B). The interaction between CYP3A7 genotype and cord blood
THg was statistically signiﬁcant (p < 0.05) for the Mediterranean
cohorts. No eﬀect modiﬁcation of CYP3A7 was evident for PDI
(Fig. 1C–D). For CYP3A5, the overall coeﬃcient for the association
between cord blood THg and MDI was positive for children carrying AA
or AG (β= 2.51; 95% CI 1.04, 3.98) (Fig. 2A) and near the null for
children carrying GG (β= 0.40; 95% CI −2.27, 1.06) (Fig. 2B). The
interaction between cord blood THg and CYP3A5 genotype was
statistically signiﬁcant (p < 0.05) for INMA-Spain and PHIME-Greece.
For PDI, the overall coeﬃcient was positive but not statistically
signiﬁcant and the interaction was signiﬁcant only for PHIME
(Fig. 2C–D). Results from the analysis of CYP3A4 rs2740574 were
similar to the CYP3A7 and CYP3A5 SNPs, but the interaction p-value in
the MDI models was< 0.05 for INMA only (Fig. 3). Coeﬃcients were
virtually the same when we included maternal ﬁsh intake in the
minimally adjusted models (Supplemental material Tables 2-4). Similar
results were observed when we used the common variables adjusted
models (Supplemental material Tables 5-7).
Eﬀect modiﬁcation of the three CYPA3 SNPs on the association
between maternal hair mercury and child neuropsychological develop-
ment was also evaluated. Results were more heterogeneous than for
cord blood THg and we did not observe any evident genetic eﬀect
modiﬁcation (Supplemental material Figs. 1–3).
We also evaluated the inﬂuence of the number of CYP3A variant
alleles (n = 0 to 3) on the modifying eﬀects on MDI and PDI. No clear
allele dosage eﬀect could be observed (data not shown).
4. Discussion
In this study of approximately 2600 children born to mothers who
Table 2
Genetic characteristics of the CYP3A single nucleotide polymorphisms and cord blood mercury levels (geometric means and 95% conﬁdence intervals) according to genotypea.
Cohort SNPs Geneb Genotype N Genotype (%) MAF (%) p-Value
HW
Hg GM (μg/L) CI 95% P-valued
NC1-Seychelles rs2257401 CYP3A7 GG+GC 145 68.7 44.8 0.906 36.19 32.97–39.72 0.526
CCc 66 31.3 38.15 34.18–42.59
rs776746 CYP3A5 AA+AG 167 79.1 54.5 0.813 36.27 33.32–39.47 0.568
GGc 44 20.9 38.75 33.78–44.46
rs2740574 CYP3A4 GG+AG 141 68.1 54.1 0.477 37.34 34.28–40.68 0.551
AAc 66 31.9 36.26 31.40–41.86
NC2-Seychelles rs2257401 CYP3A7 GG+GC 678 71.7 46.5 0.906 Na
CC 268 28.3
rs776746 CYP3A5 AA+AG 756 79.7 55.1 0.813
GG 193 20.3
rs2740574 CYP3A4 GG+AG 667 70.8 54.0 0.477
AA 275 29.2
INMA-Spain rs2257401 CYP3A7 GG+GC 123 18.2 9.5 0.948 8.48 7.40–9.73 0.711
CC 554 81.8 8.21 7.67–8.78
rs776746 CYP3A5 AA+AG 104 15.1 7.8 0.535 8.07 6.93–9.41 0.664
GG 583 84.9 8.30 7.77–8.87
rs2740574 CYP3A4 GG+AG 43 6.8 3.5 0.776 9.86 7.94–12.23 0.201
AA 593 93.2 8.22 7.70–8.78
PHIME-Italy rs2257401 CYP3A7 GG+GC 66 15.1 7.8 0.664 3.84 3.09–4.79 0.701
CC 370 84.9 3.91 3.57–4.29
rs776746 CYP3A5 AA+AG 51 11.2 5.7 0.672 3.82 2.92–5.00 0.675
GG 404 88.8 3.95 3.62–4.31
rs2740574 CYP3A4 GG+AG 29 6.3 3.2 0.484 4.50 3.30–6.13 0.711
AA 429 93.7 3.90 3.58–4.25
PHIME-Greece rs2257401 CYP3A7 GG+GC 63 23.2 12.4 0.937 5.71 4.70–6.94 0.679
CC 208 76.8 5.43 4.84–6.09
rs776746 CYP3A5 AA+AG 33 11.7 5.9 0.295 5.99 4.62–7.77 0.556
GG 248 88.3 5.54 5.00–6.14
rs2740574 CYP3A4 GG+AG 8 2.8 1.4 0.808 5.08 2.98–8.67 0.556
AA 273 97.2 5.61 5.09–6.18
CI: conﬁdence intervals. GM: geometric mean. HW: Hardy Weinberg equilibrium. MAF: minor allele frequency (for the allele that is minor allele in the majority of populations under
study).
a Alleles with higher activity: G in rs2257401, A in rs776746, and G in rs2740574.
b All three CYP3A genes are located on chromosome 7. Chromosome bands: 7q21.1 for CYP3A5, 7q22.1 for CYP3A7, 7q21.1 for CYP3A4.
c Homozygote for the minor allele.
d Refers to group diﬀerences in mercury levels (Mann-Whitney test).
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consumed ﬁsh during pregnancy, we examined a potential role for
genetic variation in CYP3A genes on the relationship between prenatal
exposure to MeHg and child neurodevelopment. For all SNPs evaluated,
there were no signiﬁcant diﬀerences seen in THg levels in cord blood,
indicating that CYP3A genotype, and presumably CYP activity, has little
inﬂuence on toxicokinetics of MeHg in the fetus.
Prior reports for all four populations showed that an increase in
prenatal Hg was not adversely associated with MDI (Davidson et al.,
2008; Llop et al., 2012; Valent et al., 2013). In this study, we found that
for a doubling of cord blood THg concentrations, children carrying a
high activity allele of CYP3A obtained higher MDI scores, and not
children carrying low activity CYP3A alleles for whom coeﬃcients
obtained were near null. One explanation for improving scores with
increasing THg might be that cord blood THg acts as a surrogate of ﬁsh
nutrients that are beneﬁcial for brain development, such as fatty acids,
vitamins or selenium. Our ﬁndings suggest that the higher activity
Fig. 1. Meta-analysis of the association between cord blood mercury concentrations and MDI and PDI scores according to the child genotype for CYP3A7 rs2257401. A) Association
between cord blood mercury and MDI scores for children with the GG+GC genotype. B) Association between cord blood mercury and MDI scores for children with the CC genotype. C)
Association between cord blood mercury and PDI scores for children with the GG+GC genotype. D) Association between cord blood mercury and PDI scores for children with the CC
genotype.G is the allele with the highest activity.Models adjusted by sex and age at testing (also by subcohort for INMA).Random eﬀects were applied if heterogeneity (I-
squared) > 50%.CI: conﬁdence intervals.*Interaction p-value < 0.1 **Interaction p-value < 0.05.
Fig. 2. Meta-analysis of the association between cord blood mercury concentrations and MDI and PDI scores according to the child genotype for CYP3A5 rs776746. A) Association
between cord blood mercury and MDI scores for children with the AA+AG genotype. B) Association between cord blood mercury and MDI scores for children with the GG genotype. C)
Association between cord blood mercury and PDI scores for children with the AA+AG genotype. D) Association between cord blood mercury and PDI scores for children with the GG
genotype.A is the allele with the highest activity.Models adjusted by sex and age at testing (also by subcohort for INMA).Random eﬀects were applied if heterogeneity (I-
squared) > 50%.CI: conﬁdence intervals.*Interaction p-value < 0.1 **Interaction p-value < 0.05.
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CYP3A alleles may modify the extent to which the beneﬁts of such
nutrients outweigh the adverse inﬂuences of mercury. Which nutrients
would fall under a positive inﬂuence of CYP3A enzyme activity remains
largely speculative; but a potential nutrient to be explored could be the
vitamin D, which metabolism has been recently related with the human
liver microsomal CYP3A4 (Cheng et al., 2016) and that has been
associated with improved mental and psychomotor development in the
Spanish cohort (Morales et al., 2012). Nevertheless, we observed
similar results for the associations between CYP3A and neurodevelop-
mental scores in the sensitivity analysis by adjusting the models by ﬁsh
consumption, which would indicate the existence of some residual
confounding, and a more in-depth analysis evaluating speciﬁc ﬁsh-
related biomarkers is needed to pinpoint which ﬁsh nutrients may
inﬂuence the associations observed.
Curiously, the strongest genetic eﬀect modiﬁcation was found in the
Mediterranean cohorts where the CYP3A high-activity alleles occur
with the lowest frequency, much lower than in the Seychelles cohorts
where no signiﬁcant eﬀect modiﬁcation was observed. This population
level diﬀerence may suggest that there are population-speciﬁc genetic
diﬀerences that inﬂuence the eﬀect of CYP3A on mercury-related
neurodevelopment. However, there could be other non-genetic factors
that may explain these cohort-speciﬁc results. For example, the study
population in Seychelles smoked less, included more high-level edu-
cated participants, and has a higher prenatal exposure to mercury. We
tried to control for these factors in the multivariable analysis but we
cannot discard the possibility of residual confounding.
We did not ﬁnd any evidence of allele-dependent dosage eﬀect for
the CYP3A genes, implying that other polymorphisms in CYP3A or
other genes explain the population diﬀerences. It is interesting to note
that no eﬀect of CYP3A genotype was found when maternal hair THg
was used as marker of prenatal MeHg exposure. This could be due to
diﬀerences in maternal hair sampling across the cohorts (hair length or
pregnancy period). Hair THg levels have been shown to correlate highly
with Hg levels in critical target tissues, such as the brain (Cernichiari
et al., 1995) but we obtained strongest associations for cord blood THg
which reﬂect more recent exposure in the third trimester of pregnancy.
We speculate that, in this study, cord blood THg better reﬂect the fetal
MeHg dose and thus is more relevant for studying interaction with the
child's CYP3A genotype for neurodevelopmental outcomes.
In the populations we studied, children carrying high activity
CYP3A alleles showed higher MDI scores as THg concentrations
increased. This is consistent with an experimental study in fruit ﬂies,
where the transgenic expression of CYP6g1, or its human homolog
CYP3A4, was seen to confer tolerance to MeHg toxicity during
development (Rand et al., 2012). However, the mechanism for this
tolerance to toxicity remains uncertain. In humans, the CYP3A enzymes
are known to be involved in the metabolism of xenobiotics primarily in
the liver but also in extrahepatic tissues including placenta, kidney,
intestines, and lung (Pavek and Dvorak, 2008). Consistent with the
notion that CYP3A genes aﬀord MeHg protection during development,
we observed that the strongest association occurred between MeHg and
CYP3A7, which is the CYP3A isoform that is expressed exclusively in
the fetal liver (Stevens et al., 2003).
Polymorphisms in the CYP3A genes are known to alter the
metabolism of some xenobiotics (Pavek and Dvorak, 2008). Since cord
blood THg concentrations were not seen to vary as a function of CYP3A
genotype, it appears that CYP3A enzymes have little inﬂuence on MeHg
toxicokinetics. An alternative explanation for the beneﬁcial eﬀects of
more active CYP3A genotypes may relate to metabolism and clearance
of toxic by-products of a MeHg insult. In this regard, CYP3A4 catalyzes
the reduction of α- and β-unsaturated aldehydes, notably, 4-hydro-
xynonenal (4-HNE) (Amunom et al., 2011), a common endogenous
product of lipid peroxidation resulting from metal toxicity (Valko et al.,
2005). Localized expression of CYP3A activity, e.g. in the brain, may
therefore have a neuroprotective function, and accordingly, reduced
CYP activity, via MeHg inhibition, could leave the brain vulnerable. In
support of this notion, inhibition of CYP3A4 or CYP2D6 activity in SH-
SY5Y human neuroblastoma cells has been shown to enhance the
neurotoxicity of MPP+ (1-methyl-4-phenylpyridinium), a neurotoxic
derivative of MPTP ((1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)
and an agent used to induce dopaminergic neuron death in models of
Parkinson's disease (Mann and Tyndale, 2010). Resolving mechanisms
by which CYP enzymes alleviate toxic eﬀects speciﬁc to MeHg will
require further studies.
Fig. 3. Meta-analysis of the association between cord blood mercury concentrations and MDI and PDI scores according to the child genotype for CYP3A4 rs2740574. A) Association
between cord blood mercury and MDI scores for children with the GG+AG genotype. B) Association between cord blood mercury and MDI scores for children with the AA genotype. C)
Association between cord blood mercury and PDI scores for children with the GG+AG genotype. D) Association between cord blood mercury and PDI scores for children with the AA
genotype.G is the allele with the highest activity.Models adjusted by sex and age at testing (also by subcohort for INMA).Random eﬀects were applied if heterogeneity (I-
squared) > 50%.CI: conﬁdence intervals.*Interaction p-value < 0.1 **Interaction p-value < 0.05.
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The main strengths of our study are the multi-cohort design and the
large study population. Furthermore, we compared diﬀerent popula-
tions that were all exposed to MeHg through ﬁsh consumption.
Additionally, children's neurodevelopment was assessed prospectively
using standardized and validated neuropsychological tests and ques-
tionnaires. The main limitation of our study was the heterogeneity in
the measure of neurodevelopment since diﬀerent editions of the Bayley
test were used. Also slightly diﬀerent child age ranges were considered.
We addressed these limitations by homogenizing the scales and using a
meta-analysis approach.
In conclusion, the magnitude of the association between prenatal
exposure to MeHg and child neuropsychological development appears
to be modiﬁed by polymorphisms in CYP3A7 and CYP3A5 genes in
some of the populations studied. These results provide some support for
the hypothesis that CYP3A genes may modify the response to MeHg-
containing ﬁsh exposure during early life development.
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